Author

F. Durbesson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Assay:proteomics· 1

Frequent Co-Authors

R. Vincentelli· 3 shared A. Anastasio· 1 shared A. Davidson· 1 shared A. Finn· 1 shared A. Harrison· 1 shared A. J. Mulholland· 1 shared B. Vidana Matteo· 1 shared C. Caillet-Saguy· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiochemistry

R. Vincentelli

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Antibodies generated in vitro and in vivo elucidate design of a thermostable ADDomer COVID-19 nasal nanoparticle vaccine

D. Buzas, H. A. Bunzel, O. Staufer, E. Milodowski, G. Edmonds, J. Bufton, B. Vidana Matteo, S. Yadav, K. Gupta, C. Fletcher, M. Kavanagh Williamson, A. Harrison, U. Borucu, J. Capin, O. Francis, , I. Berger

This study develops a thermostable ADDomer-based nanoparticle vaccine that neutralizes SARS-CoV-2 and cross-reacts with VOCs, demonstrating its potential for nasal administration.

bioRxiv · Mar 17, 2023Biochemistry

Light-inducible T cell engagers trigger, tune and shape the activation of primary T cells

M. Jaeger, A. Anastasio, S. Brustlein, R. Vincentelli, F. Durbesson, R. Char, M. Boussand, M. Lechelon, R. J. Arguello, D. Marguet, H.-T. He, R. Lasserre

The paper introduces a light-inducible T cell engager system to study how temporal TCR stimulation patterns influence T cell activation and cytokine responses.

bioRxiv · Apr 15, 2022 · PreprintImmunology

Host PDZ-containing proteins targeted by SARS-Cov-2

C. Caillet-Saguy, F. Durbesson, V. V. REZELJ, G. Gogl, Q. D. Tran, J.-C. Twizere, M. Vignuzzi, R. Vincentelli, N. Wolff

The paper identifies sixteen human PDZ binders of SARS-CoV-2 proteins E, 3a, and N, showing significant interactions and potential roles in viral replication and immune evasion.

bioRxiv · Feb 1, 2021Biochemistry